Pnc Financial Services Group, Inc. Kymera Therapeutics, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $190 Billion
- Q1 2025
A detailed history of Pnc Financial Services Group, Inc. transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 152 shares of KYMR stock, worth $4,377. This represents 0.0% of its overall portfolio holdings.
Number of Shares
152
Previous 113
34.51%
Holding current value
$4,377
Previous $4,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
181Shares Held
67.4MCall Options Held
223KPut Options Held
241K-
Price T Rowe Associates Inc Baltimore, MD6.7MShares$193 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.46MShares$186 Million2.86% of portfolio
-
Wellington Management Group LLP Boston, MA6MShares$173 Million0.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$173 Million1.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.23MShares$151 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.58B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...